First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

Clinical trial NCT07384715 · RECRUITING

Trial details

NCT number: NCT07384715
Sponsor: Genmab
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

R/R AML R/R HR-MDS Acute Myeloid Leukemia Higher-Risk Myelodysplastic Syndrome

Start date: 2026-02-16
Primary completion: 2029-10-18
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.